Jones Financial Companies
XGN icon

Jones Financial Companies’s Exagen XGN Stock Holding History

Jones Financial Companies’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$536 Hold
200
– – ﹤0.01% 4475
2025
Q4 		$1.22K Buy
+200
New +$1.82K ﹤0.01% 3969

Other funds holding XGN

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Jones Financial Companies's XGN Position: Q1 2026 in Review

Jones Financial Companies held its Exagen (XGN) position steady in Q1 2026 at 200 shares worth $536. The position accounts for ﹤0.01% of the portfolio, ranked #4475.

Jones Financial Companies first reported a position in XGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.22K in Q4 2025. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.

  • Jones Financial Companies held 200 shares of Exagen worth $536 as of Q1 2026.
  • Jones Financial Companies left its Exagen share count unchanged in Q1 2026.
  • Exagen made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4475 holding.
  • Jones Financial Companies first reported a position in Exagen in Q4 2025 and has held it in 2 quarters since.
  • Jones Financial Companies's Exagen position peaked at $1.22K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.